Home » Topics » BioWorld Science

BioWorld Science
RSS

All is loss for P53 mutations, study argues

Sep. 1, 2021

SPOP gene behind prostate cancer risk

Sep. 1, 2021

Janssen optimizes new series of PDE2A inhibitors

Sep. 1, 2021

COL13A1 and KCNMA1 are downregulated in patients with Pompe disease

Sep. 1, 2021

Mindset Pharma reports preclinical data on next-generation novel 5-MeO-DMT psychedelic analogues

Sep. 1, 2021

AcureX awarded funding to support development of drug candidates for Parkinson's disease

Sep. 1, 2021

Jacobio invests in Hebecell to advance iPSC-NK cell therapy

Sep. 1, 2021

Researchers identify genetic associations with behaviors related to self-regulation and addiction

Sep. 1, 2021

ErSO induces regression of human breast tumors in vivo

Sep. 1, 2021

Merck & Co. structure-based design efforts lead to new nucleoside PRMT5 inhibitors

Sep. 1, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...